Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal mucus refers to the hydrated, viscoelastic barrier covering the intestinal epithelium, playing a crucial role in protecting epithelial cells from pathogens, mechanical injury, and harsh luminal contents[1][4][7]. The major structural component is the **gel-forming mucin MUC2**, but many additional proteins such as FCGBP, ClCA1, ZG16, AGR2, and immunoglobulins are present[1][2][3][4]. In the colon, the mucus is organized into two layers: an inner, dense adherent layer that is nearly impenetrable to bacteria and an outer, looser layer that serves as a habitat for commensal microbes[5][6][7]. Intestinal mucus is a *biological hydrogel*, not a single molecule or drug target; it is primarily produced and secreted by **goblet cells** in the epithelium[1][4][7]. Impairments in mucus production or structure are associated with inflammatory bowel disease, susceptibility to infection, and epithelial injury[4][7]. While some drugs are formulated to interact with or penetrate mucus, the mucus itself is **not a canonical drug target** such as a receptor, enzyme, or transporter, but rather an anatomical and functional barrier.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucus.